Clinical trials test 0.16 to 4.5 mg subcutaneously once weekly (Lau 2021, Lancet)
Peptide therapy has been studied for its potential to modulate immune responses, potentially offering a way to mitigate the autoimmune aspect of celiac disease and provide support for the immune system
The future of T1D research hinges on leveraging advanced human models, such as single-cell multiomics, patient-specific data, hPSC-derived cells, and organs-on-chips, to bridge the divide between foundational animal studies and clinical pathology
Be wary of suppliers who cannot or will not provide current COAs for their products
By activating sirtuins and rejuvenating senescent muscle stem cells, 5-Amino-1MQ has the potential to enhance these processes, promoting cellular resilience, maintenance of muscle mass, the ability to burn fat, and potentially slowing down the aging process
[updated 2023 Jul 30